DIA 48th Annual Meeting
Click here to go to the previous page
Challenges of Precision Medicine: Diagnostics, Reimbursement, Partnership Co-development
Track : Track 20: Executive Program: Pioneering Partnerships
Program Code: 560
Date: Tuesday, June 26, 2012
Time: 12:00 PM to 1:30 PM  EST
CHAIR :
 Kenneth Kaitin, Tufts University School of Medicine, United States
PRESENTER (S):
 Kenneth Getz, Tufts University, United States
Felix Frueh, Medco Research Institute, United States
 Steven Romano, Pfizer Inc, United States
Paul Chew, Sanofi US, United States
 Thomas Getzen, iHEA, United States
Description
This discussion will help participants leverage real-world evidence generated during product development and throughout the product life cycle to improve the overall quality of patient care. Due to its format, this program offering is not being recorded and will not be available through the post-Annual Meeting Live Learning Center.

Learning Objectives:
Identify the improvements that need to be made to the safety and effectiveness of medical treatments in real-world practice
Evaluate the use of real-world data and comparative effectiveness research to better understand patient needs and improve access to appropriate care
Define the future of therapeutic-diagnostic co-development, its challenges and benefits.


Audio Synchronized to PowerPoint
(Code: 560)
Attendee:
  
This session is a part of:
Handout Online
View